Weight loss is a primary driver of downstream hormonal benefits, with semaglutide producing up to 15% body weight reduction over 68 weeks and a 2025 trial reporting a mean loss of 5.6 kg, compared with 2.3 kg with other treatments
Losing some lean mass alongside fat when losing this much total weight is expected
Unlike semaglutide, which acts on only the GLP-1 receptor, tirzepatide is a dual agonist that also activates the GIP (glucose-dependent insulinotropic polypeptide) receptor
The specific pattern matters less than the consistency of rotating
Before you inject, youll need to ensure that the Ozempic pen is at room temperature for the best injection experience
Clinical trial data In the STEP 1 clinical trials published in the New England Journal of Medicine (NEJM) in 2021, 1,961 participants without type 2 diabetes received semaglutide 2.4 mg once weekly, along with lifestyle modifications